Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 34.96% is 10% below its 5-year average of 38.92%, around the middle of its 5-year range (30.31%–45.46%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.11% below its 12-month average of 35.36%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
34.96%
EBITDA MARGIN AVG TTM
35.36%
EBITDA MARGIN AVG 3Y
37.65%
EBITDA MARGIN AVG 5Y
38.92%
EBITDA MARGIN AVG 10Y
35.13%
EBITDA MARGIN AVG 15Y
30.79%
EBITDA MARGIN AVG 20Y
29.60%
CURRENT VS TTM AVG
-1.11%
CURRENT VS 3Y AVG
-7.12%
CURRENT VS 5Y AVG
-10.16%
CURRENT VS 10Y AVG
-0.46%
CURRENT VS 15Y AVG
+13.55%
CURRENT VS 20Y AVG
+18.13%
Bristol-Myers Squibb Company
Market Cap
$133.37B
EBITDA Margin
34.96%
TTM Avg
35.36%
3Y Avg
37.65%
5Y Avg
38.92%
Market Cap
$137.13B
EBITDA Margin
30.87%
TTM Avg
31.21%
3Y Avg
32.47%
5Y Avg
31.98%
Market Cap
$124.86B
EBITDA Margin
24.22%
TTM Avg
25.63%
3Y Avg
25.70%
5Y Avg
26.23%
Market Cap
$124.82B
EBITDA Margin
35.99%
TTM Avg
34.83%
3Y Avg
32.83%
5Y Avg
33.22%
Market Cap
$121.09B
EBITDA Margin
41.14%
TTM Avg
20.45%
3Y Avg
32.86%
5Y Avg
36.27%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Company (BMY) | $133.37B | 34.96% | 35.36% | 37.65% | 38.92% |
| CVS Health Corp. (CVS)vs › | $133.25B | 3.73% | 3.63% | 4.02% | 4.83% |
| AstraZeneca PLC (AZN)vs › | $131.47B | 33.16% | 30.52% | 27.50% | 25.68% |
| Danaher Corporation (DHR)vs › | $137.13B | 30.87% | 31.21% | 32.47% | 31.98% |
| Stryker Corporation (SYK)vs › | $124.86B | 24.22% | 25.63% | 25.70% | 26.23% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.82B | 35.99% | 34.83% | 32.83% | 33.22% |
| Pfizer Inc. (PFE)vs › | $142.54B | 32.51% | 34.72% | 32.84% | 32.73% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.09B | 41.14% | 20.45% | 32.86% | 36.27% |
| Medtronic plc (MDT)vs › | $109.30B | 25.92% | 26.11% | 25.62% | 25.51% |
| Gilead Sciences, Inc. (GILD)vs › | $161.66B | 49.12% | 32.26% | 34.27% | 33.90% |
Gross Margin
70.2%
EBITDA Margin
35.0%
Operating Margin
28.3%
Net Margin
18.9%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 34.96% |
| 2026-03-31 | 34.46% |
| 2025-12-31 | 30.31% |
| 2025-09-30 | 38.05% |
| 2025-06-30 | 39.00% |
| 2025-03-31 | 40.26% |
| 2024-12-31 | 35.74% |
| 2024-09-30 | 41.04% |
| 2024-06-30 | 42.46% |
| 2024-03-31 | 34.28% |
| 2023-12-31 | 38.48% |
| 2023-09-30 | 41.39% |
| 2023-06-30 | 38.97% |
| 2023-03-31 | 43.06% |
| 2022-12-31 | 37.13% |
| 2022-09-30 | 42.95% |
| 2022-06-30 | 44.35% |
| 2022-03-31 | 45.46% |
| 2021-12-31 | 40.16% |
| 2021-09-30 | 38.36% |
| 2021-06-30 | 36.49% |
| 2021-03-31 | 43.94% |
| 2020-12-31 | 30.91% |
| 2020-09-30 | 38.15% |
| 2020-06-30 | 34.52% |
| 2020-03-31 | 31.58% |
| 2019-12-31 | 24.38% |
| 2019-09-30 | 32.85% |
| 2019-06-30 | 34.86% |
| 2019-03-31 | 32.99% |
| 2018-12-31 | 29.50% |
| 2018-09-30 | 32.37% |
| 2018-06-30 | 12.55% |
| 2018-03-31 | 29.58% |
| 2017-12-31 | 22.50% |
| 2017-09-30 | 23.83% |
| 2017-06-30 | 33.30% |
| 2017-03-31 | 36.68% |
| 2016-12-31 | 21.34% |
| 2016-09-30 | 29.26% |
| 2016-06-30 | 25.17% |
| 2016-03-31 | 26.83% |
| 2015-12-31 | -1.28% |
| 2015-09-30 | 17.72% |
| 2015-06-30 | 5.14% |
| 2015-03-31 | 30.34% |
| 2014-12-31 | 2.40% |
| 2014-09-30 | 20.79% |
| 2014-06-30 | 10.65% |
| 2014-03-31 | 22.30% |
| 2013-12-31 | 23.49% |
| 2013-09-30 | 23.76% |
| 2013-06-30 | 20.18% |
| 2013-03-31 | 22.66% |
| 2012-12-31 | 17.18% |
| 2012-09-30 | 20.13% |
| 2012-06-30 | 26.02% |
| 2012-03-31 | 37.75% |
| 2011-12-31 | 32.73% |
| 2011-09-30 | 34.18% |
| 2011-06-30 | 35.76% |
| 2011-03-31 | 35.54% |
| 2010-12-31 | 26.08% |
| 2010-09-30 | 36.24% |
| 2010-06-30 | 35.72% |
| 2010-03-31 | 34.66% |
| 2009-12-31 | 33.78% |
| 2009-09-30 | 29.58% |
| 2009-06-30 | 28.94% |
| 2009-03-31 | 23.19% |
| 2008-12-31 | 18.99% |
| 2008-09-30 | 26.61% |
| 2008-06-30 | 28.60% |
| 2008-03-31 | 25.81% |
| 2007-12-31 | 17.82% |
| 2007-09-30 | 21.60% |
| 2007-06-30 | 21.51% |
| 2007-03-31 | 22.36% |
| 2006-12-31 | 10.68% |
| 2006-09-30 | 16.56% |
| 2006-06-30 | 26.01% |
| 2006-03-31 | 24.44% |
| 2005-12-31 | 21.42% |
| 2005-09-30 | 25.11% |
| 2005-06-30 | 27.69% |
| 2005-03-31 | 27.67% |
| 2004-12-31 | 37.10% |
| 2004-09-30 | 25.98% |
| 2004-06-30 | 25.03% |
| 2004-03-31 | 26.02% |
| 2003-12-31 | 24.28% |
| 2003-09-30 | 29.72% |
| 2003-06-30 | 28.44% |
| 2003-03-31 | 27.74% |
| 2002-12-31 | 22.28% |
| 2002-09-30 | 27.84% |
